{
  "id": 3938729,
  "title": "#ESC26: Data in hand, Cytokinetics looks to expanded Myqorzo approval",
  "url": "https://urgent.news/2026/08/28/esc26-data-in-hand-cytokinetics-looks-to-expanded-myqorzo-approval",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-28T09:45:14.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/esc26-data-in-hand-cytokinetics-looks-to-expanded-myqorzo-approval/"
  },
  "original_language": "en",
  "account": null,
  "summary": "MUNICH — Cytokinetics’ heart drug Myqorzo could gain expanded approval next year, potentially doubling its market reach, after detailed results backed the drug’s use in a heart muscle disease. The new data, presented at the European ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}